Recruiting
Phase 3

Carbetocin

Sponsor:

ACADIA Pharmaceuticals Inc.

Code:

NCT06173531

Conditions

Hyperphagia in Prader-Willi Syndrome

Eligibility Criteria

Sex: All

Age: 5 - 30

Healthy Volunteers: Not accepted

Interventions

Carbetocin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-29. This information was provided to ClinicalTrials.gov by ACADIA Pharmaceuticals Inc. on 2025-04-03.